THE OPHTHALMOLOGY RESEARCH COMPANY
Live / Applied — Final refusal mailed (as of 14 Jan 2026)
What this means for you
Not registered yet, but its 11 Apr 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99133383
- Mark type
- Stylized text
- Filed
- 11 Apr 2025
- Attorney of record
- Michael R Rizzo
Goods and services
- Class 035 — Advertising and business services: Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Compiling and analyzing statistics, data and other sources of information for business purposes
- Class 042 — Scientific and technological services: Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical drug development services; Testing of pharmaceuticals
Owner
- ORA LLC, ANDOVER, MA, US
Prosecution history
- 18 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Mar 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 18 Mar 2026 — USE AMENDMENT ACCEPTED
- 17 Feb 2026 — AMENDMENT TO USE PROCESSING COMPLETE
- 17 Feb 2026 — USE AMENDMENT FILED
- 17 Feb 2026 — TEAS AMENDMENT OF USE RECEIVED
- 14 Jan 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 14 Jan 2026 — FINAL REFUSAL E-MAILED
- 14 Jan 2026 — FINAL REFUSAL WRITTEN
- 12 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Sept 2025 — NON-FINAL ACTION E-MAILED